The Kidney PATIENT Act of 2023 Campaign

Background

Effective January 1, 2025, CMS plans to change coverage for oral-only phosphate lowering therapies (PLTs) drugs for patients with kidney failure. This could jeopardize patients’ access to vital medications and raise dialysis treatment costs. Introduced by Reps. Earl L. “Buddy” Carter, Ann McLane Kuster, Carol Miller, and Terri Sewell, the bipartisan Kidney PATIENT Act (H.R. 5074) aims to postpone this change until 2033 or until new intravenous therapies become available. State and National stakeholders from the kidney community and beyond have called on Washington to act quickly and exclude oral-only phosphate lowering therapies (PLTs) from the End Stage Renal Disease Prospective Payment System or ESRD Bundle.

H.R. 5074 | Kidney PATIENT Act

Events

“Protecting Dialysis Patients with Kidney Failure”

Ensuring Access to Life-Saving ESRD Oral-Only Medicines within Medicare

 

Nashville, TN | November 27, 2023

1:00 pm- 3:30 pm CST

Keynote Speaker

Laura Williams, MD, MPH | Chief Medical Officer, Ardelyx

Program Agenda | Nashville ESRD Oral Only Medicines Roundtable 

 

Hosted by

National Black Caucus of State Legislators

 

In Partnership with

HEAL Collaborative and Ardelyx

Atlanta, GA | December 14 & 16, 2023

10:00 am - 12:30 pm EST

Keynote Speaker

Laura Williams, MD, MPH | Chief Medical Officer, Ardelyx| Bio

Keynote Slide Deck | Ardelyx Presentation on Oral Only Issues 

 

Program Agenda

Program I: ESRD Oral Only Meds Workshop

Program II: ESRD Oral Only Meds Workshop 

Hosted by

Cornerstone Community Baptist Church

4895 Campbellton Rd SW, Atlanta, GA 30331

 

In Partnership with

HEAL Collaborative and Ardelyx

Resources

Effective January 1, 2025, CMS plans to change coverage for oral-only phosphate lowering therapies (PLTs) drugs for patients with kidney failure. Learn more:

Ardelyx | Kidney Patient Act

 

Unless Congress passes the Kidney PATIENT Act of 2023 (H.R. 5074), patients will face new restrictions to much-needed PLTs because their coverage will be moved into the End Stage Renal Disease Prospective Payment System or “ESRD bundle” starting in 2025.

National Minority Quality Forum Action Network (NMQFAN ) | Protect Health Equity in Kidney Care

 

Americans on dialysis need help from Congress to ensure they have access to much-needed innovative treatments. Learn more about what you can do to help this effort:

https://www.kidneycareequity.org/

 

Congress Must Act to Ensure Patients Don’t Lose Access to Much-Needed Innovative Therapies:

Kidney Patient Act | Protecting Quality Care for Dialysis Patients

 

Let Your Voice Be Heard!